STOCKHOLM--(BUSINESS WIRE)--Regulatory News: BioGaia (STO:BIOGB) has signed an exclusive distributor agreement with Phillips Pharma Group for the rights to sell BioGaia ProTectis drops, tablets and ...

A study published in the Journal of Pediatrics found L. reuteri Protectis, a probiotic of BioGaia, reduced both frequency and severity of abdominal pain in children, compared to a placebo. Zvi Weizman ...

BioGaia has signed three exclusive distribution agreements that will take its oral health products into the Czech Republic, South Africa, and the Benelux region of Europe. Next Force now has exclusive ...

BioGaia reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and strategic product launches. Sales for the quarter rose by 23% to SEK 365 million, while ...

One of the beneficial gut bacteria residing in the human gut, which normally cannot survive in an environment with oxygen, can now be made oxygen-tolerant. This is a key finding in the development of ...